Podcast Episodes
Back to Search
Tariff Turmoil, FDA’s Future, Pfizer’s Obesity Setback and CEO Salaries Revealed
It’s all about tariffs again this week. No sooner had Donald Trump announced that “major” tariffs on the pharmaceutical industry would be coming “ver…
1 year, 2 months ago
Bonus: Q1 2025 Job Market Update
In this bonus episode, BioSpace’s vice president of marketing Chantal Dresner and careers editor Angela Gabriel take a look at job market perform…
1 year, 2 months ago
Breaking Down Barriers: The Nuanced Approach to Women's Representation in Medical Research
This discussion features BioSpace's head of insights Lori Ellis, Kearney partner Martin Hadosi, and Melissa Laitner, director of strategic initiative…
1 year, 3 months ago
Tariff-Triggered Recession Fears, Fallout From HHS Cuts, Knockoff GLP-1s and More
Pushback against the Trump administration’s massive government cuts exploded this weekend across America—and biopharma is no exception. Taking a deep…
1 year, 3 months ago
FDA on Fire, Novo’s Mixed Bag of Semaglutide Cardio Data, Kisunla’s EU Miss, More
Biopharma’s reaction to the forced resignation of venerable CBER director Peter Marks has been swift and furious, with former FDA Commissioner Robert…
1 year, 3 months ago
Balancing Protection and Inclusion: The Evolution of Women in Clinical Trials
Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives, National Academy of Medicine, join Lori Ellis, head of insi…
1 year, 3 months ago
Trump’s Pharma Tariffs, Monarez for CDC, Novo’s New Obesity Play, More
President Donald Trump doubled down on tariff threats targeting pharma, saying additional levies on pharmaceuticals will come “at some point,” per CN…
1 year, 3 months ago
Sarepta’s Elevidys Death, FDA’s Vaccine Move, Weldon Whiplash, PDUFAs in Cardio
A patient with Duchenne muscular dystrophy taking Sarepta’s gene therapy Elevidys has died of acute liver failure, possibly related to a recent viral…
1 year, 3 months ago
A Conversation With Mark McKenna, CEO of Mirador
On the sidelines of this year’s J.P. Morgan Healthcare Conference in San Francisco, BioSpace Senior Editor Annalee Armstrong sat down with Mark McKen…
1 year, 3 months ago
“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
Miruna Sasu, CEO of COTA, has been labeled as a disrupter in the industry. In this episode, she discusses the challenges of stringent inclusion and e…
1 year, 3 months ago